| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/04/2005 | CN1611514A Egg containing mixed IgY directed against about four antigens resulting acne and production method for its yolk powder and said mixd IgY |
| 05/04/2005 | CN1200002C Human melanin tumour monoclonal antibody, and its preparing method and use |
| 05/04/2005 | CN1199999C Human protein for promoting transform of 3T3 cell and its coding sequence |
| 05/04/2005 | CN1199998C Human protein with suppression to cance cell growth and its coding sequence |
| 05/04/2005 | CN1199997C New human protein having mouse NIH/3T3 cell conversion promoting function and its coding sequence |
| 05/04/2005 | CN1199996C New human protein having cancer cell growth in hibiting function and its coding sequence |
| 05/04/2005 | CN1199995C New Human protein having cancer inhibiting function and its coding sequence |
| 05/04/2005 | CN1199994C New human protein with cancer cell growth inhibiting function and its coding sequence |
| 05/04/2005 | CN1199693C Remedies for hypercalcemic crisis |
| 05/03/2005 | US6889145 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 05/03/2005 | US6887987 DNA encoding the human serine protease T |
| 05/03/2005 | US6887983 Purified 20 kDA presenilin 2 C-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2 |
| 05/03/2005 | US6887981 Natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 05/03/2005 | US6887975 Serpentine protein for use in the treatment of cancer |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887843 Chlamydia protein, gene sequence and uses thereof |
| 05/03/2005 | US6887683 Human G-protein coupled receptors |
| 05/03/2005 | US6887674 Artery- and vein-specific proteins and uses therefor |
| 05/03/2005 | US6887673 Containing light chain and a heavy chain peptide; anticarcinogenic agent |
| 05/03/2005 | US6887660 Detecting cancer in humans; obtain sample, incubate with binding protein, detect bound proteins or polypeptides, presence of bound protein indicates cancer |
| 05/03/2005 | US6887659 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 05/03/2005 | US6887482 Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins |
| 05/03/2005 | US6887480 For prophylaxis and therapy of pneumococcal infection, especially by Streptococcus pneumoniae |
| 05/03/2005 | US6887474 Compositions and methods for producing vascular occlusion |
| 05/03/2005 | US6887473 Administering as antitumor, antimetastasis, antiinflammatory, or anticarcinogenic agent |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887471 Method to inhibit T cell interactions with soluble B7 |
| 05/03/2005 | US6887470 Covalently bonding albumin to oligopeptide; biochemical conjugation; analyzing stability |
| 05/03/2005 | US6887469 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 05/03/2005 | US6887468 Antibody kits for selectively inhibiting VEGF |
| 05/03/2005 | US6887466 Activating the population of T cells and stimulating an accessory molecule on the surface of the T cells with a ligand; HIV immunotherapy; T cells can be genetically transduced and used for immunotherapy |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 04/28/2005 | WO2005038462A1 Method for prognostic evaluation of carcinoma using anti-p-lap antibody |
| 04/28/2005 | WO2005038031A1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 04/28/2005 | WO2005038006A2 Chimeric metabotropic glutamate receptors and uses thereof |
| 04/28/2005 | WO2005038005A2 Shc proteins as therapeutic targets in proliferative diseases |
| 04/28/2005 | WO2005037999A2 Treatment of cancer using antibodies to lrrc15 |
| 04/28/2005 | WO2005037989A2 Binding domain-immunoglobulin fusion proteins |
| 04/28/2005 | WO2005037870A1 Antibody and use of the same |
| 04/28/2005 | WO2005037869A2 Method of reducing leachate from protein a affinity media |
| 04/28/2005 | WO2005037868A2 Methods of treating nfat-related disorders |
| 04/28/2005 | WO2005037867A1 ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG |
| 04/28/2005 | WO2005037866A2 Igg3 anti rhesus-d in the line yb2/0 having a high phagocytosis activity |
| 04/28/2005 | WO2005037865A2 Ztnfr14, A TUMOR NECROSIS FACTOR RECEPTOR |
| 04/28/2005 | WO2005037854A2 Immunogenic peptides |
| 04/28/2005 | WO2005037315A1 Therapeutic agent for mesothelioma |
| 04/28/2005 | WO2005037314A1 Method for generating antibodies |
| 04/28/2005 | WO2005037313A2 Tissue repair by modulation of beta-1 integrin biological function |
| 04/28/2005 | WO2005037312A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 04/28/2005 | WO2005037303A1 Methods and compositions of ig20 and denn-sv splice variants |
| 04/28/2005 | WO2005037235A2 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof |
| 04/28/2005 | WO2005037228A2 Halogen phosphonate monoesters |
| 04/28/2005 | WO2005037209A2 A method for the separation anti-amyloid beta antibody with amyloid beta peptide |
| 04/28/2005 | WO2005037194A2 Collagen interactions with prostate cancer cells |
| 04/28/2005 | WO2005023302A3 Anti-cd20 therapy of ocular disorders |
| 04/28/2005 | WO2005023300A3 Method for treating, preventing and/or diagnosing cancer, related to the use of mal2 polypeptide |
| 04/28/2005 | WO2005019431A3 Selective inhibition of toll-like receptor-2 |
| 04/28/2005 | WO2005019266A3 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2005 | WO2005005481A3 Combination therapy for gastroenteric diseases caused by microorganisms |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004106917A3 Method for the selection of epitopes for immunotherapy |
| 04/28/2005 | WO2004099251A3 Compositions and methods for treatment of cryptococcosis |
| 04/28/2005 | WO2004090135A3 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol |
| 04/28/2005 | WO2004076618A8 Genetically modified non-human mammals and cells |
| 04/28/2005 | WO2004075988A3 Methods of immunomodulation in animals |
| 04/28/2005 | WO2004064784A3 Composition and method for preventing or treating a virus infection |
| 04/28/2005 | WO2004044160A3 Muc1 interference rna compositions and methods derived therefrom |
| 04/28/2005 | WO2004041846A3 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES |
| 04/28/2005 | WO2004032622A3 Production of peptides in plants as viral coat protein fusions |
| 04/28/2005 | WO2003095971A3 Posh nucleic acids, polypeptides and related methods |
| 04/28/2005 | WO2003093493A3 Pregnancy detection |
| 04/28/2005 | WO2003083062A8 Anti-il-tif antibodies and methods of using in inflammation |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | US20050090658 Comprises polymorphic variations/point mutations linked to cation channel dysfunctions; genetic engineering; treansgenic animal; antibody |
| 04/28/2005 | US20050090648 Humanized antibodies |
| 04/28/2005 | US20050090647 Pharmaceutical compositions for treating arthritis and inflammatory disease |
| 04/28/2005 | US20050090439 Vaccine for the prevention and treatment of Alzheimer's and amyloid related diseases |
| 04/28/2005 | US20050090436 Human tumor necrosis factor receptors TR21 and TR22 |
| 04/28/2005 | US20050089984 Having a specific amino acid sequence, especially fused to a heterologous polypeptide; induces apoptosis |
| 04/28/2005 | US20050089981 Cucleic acid cotnaining a specific nucleotide sequence which encodes a polypeptide which elongates alpha -linolenic acid by two or more carbon atoms whereas gamma -lino-lenic is not elongated |
| 04/28/2005 | US20050089958 Cytokines which induce mammalian cell apoptosis; tumor necrosis factors; cancer, gliomas |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089929 Binding native human tissue factor (TF) and does not substantially bind non-native tissue factor; superior anticoagulant activity by binding with high affinity and specificity; reducing cancer cell tissue factor activity and detecting cancer cells that express TF; factor X binding is inhibited |
| 04/28/2005 | US20050089928 Antibodies to magmas and uses thereof |
| 04/28/2005 | US20050089917 Novel kinases and uses thereof |
| 04/28/2005 | US20050089912 Nucleic acids having polynucleotide sequences to encode two novel splice variant isoforms of nuclear factor kappa-B, subunit 1 (NFKB1) called NFKB1sv1 and NFKB1sv2; screening for agonist and antagonist ligands to bind to the new isoforms; antiinflammatory, - carcinogenic agents; AIDS;lupus; viricides |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089881 Superficial zone protein-binding molecules and uses thereof |
| 04/28/2005 | US20050089880 Which have a SET domain, such deregulation being of importance in certain cancers; SET domains are protein methyltransferase enzymes |
| 04/28/2005 | US20050089869 GlcNac phosphotransferase of the lysosomal targeting pathway |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089866 Identifying modulators for the treatment and prevention of diabetes, pain, obesity, nervous system, inflammatory, cell proliferative and liver disorders |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells |
| 04/28/2005 | US20050089527 Neisseria meningitidis (Nm) polynucleotides and polypeptides; diagnostic. prophylactic and therapeutic uses |